On January 21, 2025, President Trump announced the US withdrawal from the World Health Organization (WHO), reigniting concerns over the agency’s independence and its response to COVID-19. As the largest historical funder of the WHO, the US exit threatens future funding and global health coordination. The decision raises key implications for the biotech industry, including … Trump’s Move to Ditch the WHO Again: Day 1 Sees a Slew of Executive Orders Signed Off Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.